Related Experiment Videos

[There is no formula that can numerically answer questions about heredity and environment]

Lakartidningen

|August 13, 1998

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Evaluation of the effects of AZD3480 on cardiac repolarization: a thorough QT/QTc study using moxifloxacin as a positive control.

Clinical pharmacology and therapeutics·2010

Disposition of debrisoquine and nortriptyline in Korean subjects in relation to CYP2D6 genotypes, and comparison with Caucasians.

British journal of clinical pharmacology·2003

Workplace drug testing (WDT) likely to increase in Europe. Report from the First European Symposium on WDT including selected abstracts.

European journal of clinical pharmacology·2000

Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes.

British journal of clinical pharmacology·2000

Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.

Pharmacogenetics·2000

Lack of polymorphism of the conversion of losartan to its active metabolite E-3174 in extensive and poor metabolizers of debrisoquine (cytochrome P450 2D6) and mephenytoin (cytochrome P450 2C19).

European journal of clinical pharmacology·1999

See all related articles